Wilmot CA[au] - Search Results

Year	Number of Results
1984	1
1986	1
1987	1
1988	1
1989	2
1990	2
1992	1
1994	1
1995	2
1996	2
1997	1
2022	0

1

Effects of chronic intrahippocampal infusion of lipopolysaccharide in the rat.

Szczepanik AM, Fishkin RJ, Rush DK, Wilmot CA. Szczepanik AM, et al. Among authors: wilmot ca. Neuroscience. 1996 Jan;70(1):57-65. doi: 10.1016/0306-4522(95)00296-u. Neuroscience. 1996. PMID: 8848136

2

The pharmacological profile of iloperidone, a novel atypical antipsychotic agent.

Szewczak MR, Corbett R, Rush DK, Wilmot CA, Conway PG, Strupczewski JT, Cornfeldt M. Szewczak MR, et al. Among authors: wilmot ca. J Pharmacol Exp Ther. 1995 Sep;274(3):1404-13. J Pharmacol Exp Ther. 1995. PMID: 7562515

3

Effects of diet and obesity on brain alpha 1- and alpha 2-noradrenergic receptors in the rat.

Wilmot CA, Sullivan AC, Levin BE. Wilmot CA, et al. Brain Res. 1988 Jun 21;453(1-2):157-66. doi: 10.1016/0006-8993(88)90154-0. Brain Res. 1988. PMID: 2841011

4

3-[[(Aryloxy)alkyl]piperidinyl]-1,2-benzisoxazoles as D2/5-HT2 antagonists with potential atypical antipsychotic activity: antipsychotic profile of iloperidone (HP 873).

Strupczewski JT, Bordeau KJ, Chiang Y, Glamkowski EJ, Conway PG, Corbett R, Hartman HB, Szewczak MR, Wilmot CA, Helsley GC. Strupczewski JT, et al. Among authors: wilmot ca. J Med Chem. 1995 Mar 31;38(7):1119-31. doi: 10.1021/jm00007a009. J Med Chem. 1995. PMID: 7707315

5

Ex vivo studies with iloperidone (HP 873), a potential atypical antipsychotic with dopamine D2/5-hydroxytryptamine2 receptor antagonist activity.

Szczepanik AM, Brougham LR, Roehr JE, Conway PG, Ellis DB, Wilmot CA. Szczepanik AM, et al. Among authors: wilmot ca. J Pharmacol Exp Ther. 1996 Aug;278(2):913-20. J Pharmacol Exp Ther. 1996. PMID: 8768747

6

Preclinical anxiolytic profiles of 7189 and 8319, novel non-competitive NMDA antagonists.

Dunn RW, Corbett R, Martin LL, Payack JF, Laws-Ricker L, Wilmot CA, Rush DK, Cornfeldt ML, Fielding S. Dunn RW, et al. Among authors: wilmot ca. Prog Clin Biol Res. 1990;361:495-512. Prog Clin Biol Res. 1990. PMID: 1981268

7

Effects of acute and chronic treatments with clozapine and haloperidol on serotonin (5-HT2) and dopamine (D2) receptors in the rat brain.

Wilmot CA, Szczepanik AM. Wilmot CA, et al. Brain Res. 1989 May 22;487(2):288-98. doi: 10.1016/0006-8993(89)90833-0. Brain Res. 1989. PMID: 2525063

8

Effects of ritanserin on haloperidol-induced dopamine (D2) receptor up-regulation in the rat.

Szczepanik AM, Wilmot CA. Szczepanik AM, et al. Among authors: wilmot ca. Neurosci Lett. 1997 Aug 8;231(2):91-4. doi: 10.1016/s0304-3940(97)00527-2. Neurosci Lett. 1997. PMID: 9291148

9

The effects of phencyclidine on fighting in differentially housed mice.

Wilmot CA, Vanderwende C, Spoerlein MT. Wilmot CA, et al. Pharmacol Biochem Behav. 1987 Nov;28(3):341-6. doi: 10.1016/0091-3057(87)90450-3. Pharmacol Biochem Behav. 1987. PMID: 3685068

10

Behavioral responses to apomorphine and amphetamine in differentially housed mice.

Wilmot CA, Vander Wende C, Spoerlein MT. Wilmot CA, et al. Psychopharmacology (Berl). 1984;84(1):105-8. doi: 10.1007/BF00432036. Psychopharmacology (Berl). 1984. PMID: 6436876

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results